VOYA Investment Management
ADCT icon

VOYA Investment Management’s ADC Therapeutics ADCT Stock Holding History

VOYA Investment Management’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65.2K Buy
17,395
+3,020
+21% +$11.9K ﹤0.01% 2246
2025
Q4 		$50.7K Buy
14,375
+805
+6% +$3.27K ﹤0.01% 2340
2025
Q3 		$54.3K Sell
13,570
-8,341
-38% -$26.3K ﹤0.01% 2377
2025
Q2 		$58.7K Sell
21,911
-362
-2% -$761 ﹤0.01% 2574
2025
Q1 		$31.4K Sell
22,273
-1,513
-6% -$2.57K ﹤0.01% 2588
2024
Q4 		$47.3K Sell
23,786
-1,613
-6% -$4.22K ﹤0.01% 2690
2024
Q3 		$80K Buy
25,399
+1,279
+5% +$4.03K ﹤0.01% 2703
2024
Q2 		$76.2K Buy
+24,120
New +$95.9K ﹤0.01% 2734

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VOYA Investment Management's ADCT Position: Q1 2026 in Review

VOYA Investment Management increased its ADC Therapeutics (ADCT) stake by 21% in Q1 2026, buying an estimated $11.9K and bringing the position to 17,395 shares worth $65.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2246.

VOYA Investment Management first reported a position in ADCT in Q2 2024 and has held it in 8 quarters since. The position peaked at $80K in Q3 2024. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

  • VOYA Investment Management held 17,395 shares of ADC Therapeutics worth $65.2K as of Q1 2026.
  • VOYA Investment Management bought 3,020 ADC Therapeutics shares in Q1 2026, an estimated $11.9K.
  • ADC Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2246 holding.
  • VOYA Investment Management first reported a position in ADC Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • VOYA Investment Management's ADC Therapeutics position peaked at $80K in Q3 2024.
  • 118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.